Moffitt Cancer Center study educates oncologists on LGBTQ+ health concerns

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Moffitt Cancer Center is launching a nationwide study to help educate oncologists and address health care disparities among LGBTQ+ patients.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

“When I joined ASCO in 2001, the most important thing to me was networking. I savored the opportunities to come to the annual meeting to meet and to talk with those who had led the studies that would inform standards of care, particularly in gynecologic oncology,” said Don S. Dizon. 
Cancer survivors who identify as lesbian, gay, bisexual, transgender, queer, or anything other than straight and cisgender experience more chronic health conditions, disabilities, and other physical and cognitive limitations than non-LGBTQ+ cancer survivors; however, the prevalence of most conditions was highest among transgender or gender non-conforming individuals, according to a study published in Cancer Epidemiology, Biomarkers & Prevention.

Don Dizon, director of the Pelvic Malignancies Program at Lifespan Cancer Institute, head of community outreach and engagement at Legorreta Cancer Center, and director of medical oncology at Rhode Island Hospital, spoke with NFN Scout, executive director of the National LGBT Cancer Network, on Your Stories: Conquering Cancer podcast. In this episode, published June 25,...

Login